Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
Humanity is closer to stopping HIV, and the biggest obstacle is the price of the drug that will do itLenacapavir shows 100% efficacy in preventing HIV infections in women with simple administration.It is not a vaccine but highly effective, sparking enthusiasm in the fight against HIV.
Diesel, oil, condoms: Indian transgender sex workers teach truckers about AidsCondom use is vital for HIV prevention among truck drivers frequented by transgender sex workers.
Dr. Demetre Daskalakis, the White House's mpox response deputy coordinator, sure knows how to get our attention - QueertyDr. Daskalakis is a key figure in HIV prevention and public health advocacy, especially within the LGBTQ+ community.
Over 1,000 on Dublin clinic's waiting list for HIV-prevention drug PrEPDelays in accessing HIV Pre-Exposure Prophylaxis (PrEP) have been reported, despite high demand and its effectiveness in reducing infection risk.
HIV groups criticise decision not to recommend long-acting PrEP for NHS useNICE's decision against recommending CAB-LA limits access to HIV prevention methods for underserved populations in the UK.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
Humanity is closer to stopping HIV, and the biggest obstacle is the price of the drug that will do itLenacapavir shows 100% efficacy in preventing HIV infections in women with simple administration.It is not a vaccine but highly effective, sparking enthusiasm in the fight against HIV.
Diesel, oil, condoms: Indian transgender sex workers teach truckers about AidsCondom use is vital for HIV prevention among truck drivers frequented by transgender sex workers.
Dr. Demetre Daskalakis, the White House's mpox response deputy coordinator, sure knows how to get our attention - QueertyDr. Daskalakis is a key figure in HIV prevention and public health advocacy, especially within the LGBTQ+ community.
Over 1,000 on Dublin clinic's waiting list for HIV-prevention drug PrEPDelays in accessing HIV Pre-Exposure Prophylaxis (PrEP) have been reported, despite high demand and its effectiveness in reducing infection risk.
HIV groups criticise decision not to recommend long-acting PrEP for NHS useNICE's decision against recommending CAB-LA limits access to HIV prevention methods for underserved populations in the UK.
Religious Conservatives Trying to End Insurance Coverage of Incredibly Effective Anti-HIV DrugThe Supreme Court is reviewing a case challenging the Affordable Care Act's coverage of HIV prevention drugs on the basis of religious rights.
Biden proposes new rule eliminating cost sharing for injectable PrEPThe Biden administration proposed a new rule mandating insurers to provide injectable PrEP drugs without cost-sharing to increase HIV prevention access.
Religious Conservatives Trying to End Insurance Coverage of Incredibly Effective Anti-HIV DrugThe Supreme Court is reviewing a case challenging the Affordable Care Act's coverage of HIV prevention drugs on the basis of religious rights.
Biden proposes new rule eliminating cost sharing for injectable PrEPThe Biden administration proposed a new rule mandating insurers to provide injectable PrEP drugs without cost-sharing to increase HIV prevention access.
The Most Important Breakthroughs of 20242023 highlights include breakthroughs in gene therapy for sickle-cell anemia and a new HIV prevention drug that shows remarkable efficacy.
A new way to prevent HIV delivers dramatic results in trialLenacapavir injection proved more effective than daily PrEP pills, showing promise for HIV prevention among women in sub-Saharan Africa.
Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.
Doctor behind trial of HIV prevention drug recounts breakthrough momentA new HIV prevention drug, lenacapavir, showed 100% protection for women aged 16 to 25 in South Africa and Uganda.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ NationLenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
Gamechanger' HIV prevention drug to be made available cheaply in 120 countriesGilead has agreed to make lenacapavir available cheaply in 120 countries, but many high-HIV burden nations are excluded, creating access issues.
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?Gilead's lenacapavir shows exceptional efficacy in preventing HIV and is a potential game-changer in the global fight against AIDS.
A new way to prevent HIV delivers dramatic results in trialLenacapavir injection proved more effective than daily PrEP pills, showing promise for HIV prevention among women in sub-Saharan Africa.
Experts say a twice-yearly injection that offers 100 percent protection against HIV is 'stunning'Twice-yearly shots for AIDS were 100 percent effective in preventing infections in women, with high potential for broader use as a preventative measure.
Doctor behind trial of HIV prevention drug recounts breakthrough momentA new HIV prevention drug, lenacapavir, showed 100% protection for women aged 16 to 25 in South Africa and Uganda.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ NationLenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
Gamechanger' HIV prevention drug to be made available cheaply in 120 countriesGilead has agreed to make lenacapavir available cheaply in 120 countries, but many high-HIV burden nations are excluded, creating access issues.
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?Gilead's lenacapavir shows exceptional efficacy in preventing HIV and is a potential game-changer in the global fight against AIDS.
Session 3: NIMH 75th Anniversary Event 3The integration of cultural and identity considerations is vital in health interventions for marginalized communities.
Australia running low on HIV-prevention drug PrEP as experts warn users to plan aheadAustralia faces a shortage of PrEP medication crucial for HIV prevention, prompting calls for users to plan ahead.
New HIV preventive strategy sparks excitement and protests at AIDS conferenceThe new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.
Injectable HIV medication: What you need to know DW 07/19/2024Injectable cabotegravir offers a new option in HIV prevention and treatment.
A Fading Weapon in the H.I.V. Fight: CondomsDecline in condom use among gay and bisexual men, especially young and Hispanic individualsPublic health focus on PrEP may have overshadowed condom promotion
An "ultra" PrEP injection just three times a year could be on the wayApproval of new PrEP injection with potentially longer dosing intervalsResults of trial for cabotegravir ultra long-acting formulation presented at CROI 2024
New HIV preventive strategy sparks excitement and protests at AIDS conferenceThe new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.
Injectable HIV medication: What you need to know DW 07/19/2024Injectable cabotegravir offers a new option in HIV prevention and treatment.
A Fading Weapon in the H.I.V. Fight: CondomsDecline in condom use among gay and bisexual men, especially young and Hispanic individualsPublic health focus on PrEP may have overshadowed condom promotion
An "ultra" PrEP injection just three times a year could be on the wayApproval of new PrEP injection with potentially longer dosing intervalsResults of trial for cabotegravir ultra long-acting formulation presented at CROI 2024
I Kissed A Boy star appears in HIV documentary following vaccine trialRaising awareness about HIV prevention and the importance of PrEP is crucial to ending new cases of the virus by 2030.
HIV transmissions down by 12%. One age group in particular is bringing those numbers down. - LGBTQ NationHIV infections among men decreased by 12% from 2018 to 2022, with the largest decline seen in men aged 13 to 24.
Opinion: Give Californians same medication access that Australians, Canadians, Coloradans enjoyCalifornia expands access to PrEP and PEP medications without doctor's prescription.Canada and Australia showcase successful pharmacist prescribing models for common conditions.
HIV cases are increasing among younger queer Latinos. Here's why. - LGBTQ NationYoung Latino men have a rising share of new HIV infections, despite being a minority in the U.S. population.
New Drug Provides Total Protection From H.I.V. in Trial of Young African WomenTwice-yearly injection of lenacaprivir provided total protection against H.I.V. in a clinical trial in Africa.
Green Party removes HIV image from online manifesto after backlashThe Green Party faced backlash for an image in its manifesto depicting people with HIV as coughing, later replaced with a hand holding a pill.